International Drug Pricing Comments Sought For Commerce Department Study
This article was originally published in The Pink Sheet Daily
Executive Summary
The International Trade Administration's review will attempt to gauge potential impact on U.S. prices from changes in foreign prices. The study, which is mandated by the Medicare Rx law, also is aimed at assessing the relationship between pricing and R&D.